Evidence for the role of peroxisome proliferator-activated receptor-β/δ in the development of spinal cord injury[S]

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 2, 2010, Pages 465-477

  Paterniti, Irene ^a   Esposito, Emanuela ^a,b   Mazzon, Emanuela ^a   Galuppo, Maria ^a   Di Paola, Rosanna ^b   Bramanti, Placido ^b   Kapoor, Amar ^c   Thiemermann, Christoph ^c   Cuzzocrea, Salvatore ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; CYTOKINE; DNA NUCLEOTIDYLEXOTRANSFERASE; FAS LIGAND; GSK 0660; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYL 3 [[(2 (METHOXY) 4 PHENYL)AMINO]SULFONYL] 2 THIOPHENECARBOXYLATE; MYELOPEROXIDASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ANTAGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLIP; CONTROLLED STUDY; CONVALESCENCE; DISEASE COURSE; DRUG EFFECT; DURA MATER; EDEMA; ENZYME ACTIVITY; FORCE; LAMINECTOMY; LIMB; MALE; MOUSE; MYELITIS; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPINAL CORD INJURY; TISSUE INJURY;

ANIMALS; APOPTOSIS; CYTOKINES; ENZYME INDUCTION; FAS LIGAND PROTEIN; MALE; MICE; NEUTROPHIL INFILTRATION; NITRIC OXIDE SYNTHASE; PEROXIDASE; PPAR DELTA; PPAR-BETA; SPINAL CORD INJURIES; SULFONES; THIAZOLES; THIOPHENES; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE;

EID: 77951039604     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.165605     Document Type: Article

References (40)

1. Ackery A, Robins S, and Fehlings MG (2006) Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 23:604-616. (Pubitemid 43728050)
2. Alexander SP, Mathie A, and Peters JA (2008) Guide to Receptors and Channels (GRAC), 3rd ed. Br J Pharmacol 153 (Suppl 2):S1-S209. (Pubitemid 351415518)
3. Batchelor PE, Porritt MJ, Martinello P, Parish CL, Liberatore GT, Donnan GA, and Howells DW (2002) Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge. Mol Cell Neurosci 21:436-453. (Pubitemid 36062730)
4. Beattie MS, Farooqui AA, and Bresnahan JC (2000) Review of current evidence for apoptosis after spinal cord injury. J Neurotrauma 17:915-925.
5. Berg D, Holzmann C, and Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752-762.
6. Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, and Yezierski RP (1998) Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18:3251-3260. (Pubitemid 28186018)
7. Casha S, Yu WR, and Fehlings MG (2001) Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 103:203-218. (Pubitemid 32304360)
8. Chittenden T, Harrington EA, O'Connor R, Flemington C, Lutz RJ, Evan GI, and Guild BC (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374:733-736.
9. Cuzzocrea S (2006) Peroxisome proliferator-activated receptors and acute lung injury. Curr Opin Pharmacol 6:263-270.
10. Di Paola R and Cuzzocrea S (2007) Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury. Naunyn Schmiedebergs Arch Pharmacol 375:157-175. (Pubitemid 46525445)
11. Ding G, Cheng L, Qin Q, Frontin S, and Yang Q (2006) PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 40:821-828. (Pubitemid 43817042)
12. Esposito E, Cuzzocrea S, and Meli R (2006) Peroxisome proliferator-activated receptors and shock state. ScientificWorldJournal 6:1770-1782. (Pubitemid 46049731)
13. Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muià C, Bramanti P, and Cuzzocrea S (2006) Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316:1006-1016.
14. Glass CK and Ogawa S (2006) Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6:44-55.
15. Hansen JB, Zhang H, Rasmussen TH, Petersen RK, Flindt EN, and Kristiansen K (2001) Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling. J Biol Chem 276:3175-3182. (Pubitemid 37411609)
16. Haskova Z, Hoang B, Luo G, Morgan LA, Billin AN, Barone FC, Shearer BG, Barton ME, and Kilgore KS (2008) Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARbeta/delta ligand GW0742. Inflamm Res 57:314-321.
17. Iwashita A, Muramatsu Y, Yamazaki T, Muramoto M, Kita Y, Yamazaki S, Mihara K, Moriguchi A, and Matsuoka N (2007) Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo. J Pharmacol Exp Ther 320:1087-1096. (Pubitemid 46294065)
18. Joshi M and Fehlings MG (2002) Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology. J Neurotrauma 19:175-190. (Pubitemid 34184609)
19. Kapoor A, Collino M, Castiglia S, Fantozzi R, and Thiemermann C (2009) Activation of peroxisome proliferator-activated receptor-beta/delta attenuates myocardial ischemia/reperfusion injury in the rat. Shock [Epub ahead of print].
20. Kilgore KS and Billin AN (2008) PPARbeta/delta ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 9:463-469.
21. Kim DJ, Bility MT, Billin AN, Willson TM, Gonzalez FJ, and Peters JM (2006) PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. Cell Death Differ 13:53-60.
22. Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, et al. (2006) PPARdelta regulates glucose metabolism and insulin sensitivity. Proc Natl Acad Sci USA 103:3444-3449. (Pubitemid 43346488)
23. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, and Wu KK (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481-1487. (Pubitemid 44288972)
24. Matsuura H, Adachi H, Smart RC, Xu X, Arata J, and Jetten AM (1999) Correlation between expression of peroxisome proliferator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells. Mol Cell Endocrinol 147:85-92. (Pubitemid 29090396)
25. Mullane K (1989) Neutrophil-platelet interactions and post-ischemic myocardial injury. Prog Clin Biol Res 301:39-51.
26. Nesic-Taylor O, Cittelly D, Ye Z, Xu GY, Unabia G, Lee JC, Svrakic NM, Liu XH, Youle RJ, Wood TG, et al. (2005) Exogenous Bcl-xL fusion protein spares neurons after spinal cord injury. J Neurosci Res 79:628-637. (Pubitemid 40476441)
27. Ohkawa H, Ohishi N, and Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358. (Pubitemid 9194347)
28. Oliver WR Jr., Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, et al. (2001) A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306-5311.
29. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, and Petratos S (2004) Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiology of Disease 15:415-436. (Pubitemid 38429958)
30. Ricote M, Valledor AF, and Glass CK (2004) Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis. Arterioscler Thromb Vasc Biol 24:230-239. (Pubitemid 38202188)
31. Rivlin AS and Tator CH (1978) Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol 10:38-43.
32. Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer X, Laguna JC, Michalik L, Wahli W, et al. (2008) Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2. Diabetes 57:2149-2157.
33. Saluja I, Granneman JG, and Skoff RP (2001) PPAR delta agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 33:191-204. (Pubitemid 32219128)
34. Sirin BH, Ortaç R, Cerrahoolu M, Saribülbül O, Baltalarli A, Celebisoy N, Ipkesen I, and Rendeci O (2002) Ischaemic preconditioning reduces spinal cord injury in transient ischaemia. Acta Cardiol 57:279-285.
35. Straus DS and Glass CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551-558. (Pubitemid 350101420)
36. Takata Y, Liu J, Yin F, Collins AR, Lyon CJ, Lee CH, Atkins AR, Downes M, Barish GD, Evans RM, et al. (2008) PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 105:4277-4282. (Pubitemid 351754371)
37. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, et al. (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA 100:15924-15929. (Pubitemid 38021091)
38. Tator CH and Koyanagi I (1997) Vascular mechanisms in the pathophysiology of human spinal cord injury. J Neurosurg 86:483-492. (Pubitemid 27097095)
39. Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, and Glass CK (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 100:6712-6717. (Pubitemid 36666645)
40. Yue TL, Nerurkar SS, Bao W, Jucker BM, Sarov-Blat L, Steplewski K, Ohlstein EH, and Willette RN (2008) In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J Pharmacol Exp Ther 325:466-474. (Pubitemid 351574787)